FELINIUM Trademark

Trademark Overview


On Monday, April 11, 2022, a trademark application was filed for FELINIUM with the United States Patent and Trademark Office. The USPTO has given the FELINIUM trademark a serial number of 97357926. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, October 1, 2024. This trademark is owned by Vanda Pharmaceuticals Inc.. The FELINIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; ...
felinium

General Information


Serial Number97357926
Word MarkFELINIUM
Filing DateMonday, April 11, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of a behavioral stressor; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Trademark Events


Event DateEvent Description
Thursday, April 14, 2022NEW APPLICATION ENTERED
Monday, April 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 23, 2023ASSIGNED TO EXAMINER
Wednesday, February 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2023ASSIGNED TO EXAMINER
Wednesday, July 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2024SOU EXTENSION 2 GRANTED
Wednesday, October 2, 2024SOU EXTENSION 2 FILED
Friday, February 2, 2024SOU EXTENSION 1 GRANTED
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, February 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 2, 2024SOU EXTENSION 1 FILED